Cargando…

Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C

Detalles Bibliográficos
Autores principales:	Erbe, A K, Wang, Wei, Grzywacz, B, Ranheim, E A, Hank, J A, Kim, K, Carmichael, L, Seo, S, Mendonca, E A, Song, Y, Hong, F, Gascoyne, R D, Paietta, E, Horning, S H, Kahl, B, Sondel, P M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991291/ http://dx.doi.org/10.1186/2051-1426-1-S1-P243

Ejemplares similares

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1
por: O'Connor, Geraldine M., et al.
Publicado: (2015)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
por: Graef, Thorsten, et al.
Publicado: (2009)

KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genes
por: Hoteit, R., et al.
Publicado: (2014)

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides
por: Hò, Gia-Gia T., et al.
Publicado: (2020)

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1
por: Burian, Aura, et al.
Publicado: (2016)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

KIR2DS5 in the presence of HLA-C C2 protects against endometriosis
por: Nowak, Izabela, et al.
Publicado: (2015)

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial
por: Feils, A. S., et al.
Publicado: (2023)

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
por: Wauquier, Nadia, et al.
Publicado: (2010)

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2016)

Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma
por: Koehn, Tony A., et al.
Publicado: (2012)

Editorial: Role of HLA and KIR in Viral Infections
por: de Wit, Jelle, et al.
Publicado: (2016)

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
por: Muriuki, Beatrice M., et al.
Publicado: (2023)

Role of KIR3DS1 in human diseases
por: Körner, Christian, et al.
Publicado: (2012)

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy
por: Wang, Wei, et al.
Publicado: (2015)

KIR2DS5 allotypes that recognize the C2 epitope of HLA‐C are common among Africans and absent from Europeans
por: Blokhuis, Jeroen H., et al.
Publicado: (2017)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

Uptake of CCR7 by KIR2DS4(+) NK Cells Is Induced upon Recognition of Certain HLA-C Alleles
por: Pesce, Silvia, et al.
Publicado: (2015)

Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C
por: Sim, Malcolm J. W., et al.
Publicado: (2019)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
por: Erbe, Amy K, et al.
Publicado: (2023)

Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy
por: Kennedy, Philippa R., et al.
Publicado: (2016)

The role of KIR and HLA interactions in pregnancy complications
por: Colucci, Francesco
Publicado: (2017)

KIR and HLA-C genes in male infertility
por: Wilczyńska, Karolina, et al.
Publicado: (2020)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation
por: Legaz, Isabel, et al.
Publicado: (2019)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

Remarkably Low KIR and HLA Diversity in Amerindians Reveals Signatures of Strong Purifying Selection Shaping the Centromeric KIR Region
por: de Brito Vargas, Luciana, et al.
Publicado: (2021)

Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children
por: Ruiz-Extremera, A., et al.
Publicado: (2017)

KIR-HLA and Maternal-Infant HIV-1 Transmission in Sub-Saharan Africa
por: Paximadis, Maria, et al.
Publicado: (2011)

Activating KIR/HLA complexes in classic Kaposi's Sarcoma
por: Guerini, Franca R, et al.
Publicado: (2012)

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy
por: Jarduli, Luciana Ribeiro, et al.
Publicado: (2013)

Editorial: HLA and KIR Diversity and Polymorphisms: Emerging Concepts
por: Maiers, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7dm2elc48u09qer4flcl8nhb0v